Whistleblowing reporting systems
We help with implementation and processing!
Authors: Gisela Ernst and Dominique Korbel
Telemedicine is gaining ground internationally and nationally. As promising and valuable as these procedures are for healthcare, their legal classification is often difficult, both nationally and at the EU level.
The legal questions under EU law are, on the one hand, of a secondary law nature. The central question here is what is to be understood as telemedicine within the framework of EU law and whether EU law regulates the practice of telemedicine. In this context, it is necessary to examine the applicability of the Patients’ Rights Directive (Directive 2011/24/EU), the Professional Qualifications Directive (Directive 2005/36/EC), and the E-Commerce Directive (Directive 2000/31/EC). On the other hand, at the level of primary law, the question arises as to whether national provisions that regulate the practice of telemedicine in more detail impair the exercise of fundamental freedoms (in particular the freedom of establishment).
All these questions are the subject of a current preliminary ruling procedure (ECJ C-115/24) in which our law firm is involved. The recently published Opinion of the Advocate General provides a preliminary assessment of these questions and indicates an initial tendency. The Advocate General’s assessment can be summarized as follows:
The Advocate General thus clearly answers the long-debated question of whether the country-of-origin principle or the country-of-destination principle applies in the case of cross-border telemedicine in favor of the country-of-origin principle. If a service is permitted in the Member State from which the treatment is provided, then it may be delivered cross-border via ICT to another Member State. However, this does not apply to services that are also partially provided physically, as this does not constitute telemedicine.
It remains to be seen whether the ECJ will follow the Advocate General’s assessments. In addition, several follow-up questions remain open for all telemedicine providers and all those entrusted with the organization and financing of the healthcare system. The decision will be of significant relevance far beyond the individual case.
Our healthcare law experts will be happy to keep you up to date on all these developments and are available to answer any further questions you may have on the topics of telemedicine and digitalization in the healthcare sector.
This article is for general information only and does not replace legal advice. Haslinger / Nagele Rechtsanwälte GmbH assumes no liability for the content and correctness of this article.
14. May 2025
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information